Drug intelligence / Profile preview

MOOV Lotion

Development stage: Unknown
Lead developer: Ego Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

MOOV Lotion is a topical, naturally-based head lice treatment developed by Ego Pharmaceuticals. It contains a combination of Eucalyptus oil (11.0% w/w) and *Leptospermum petersonii* (Lemon-scented tea tree) leaf oil (1.0% w/w). Unlike traditional synthetic pediculicides such as permethrin or malathion, MOOV Lotion utilizes natural essential oils to interfere with the biochemical and neurological mechanisms of the head louse (*Pediculus humanus capitis*), leading to death by poisoning. It is indicated for the treatment of head lice and their eggs (nits), typically requiring three applications spaced seven days apart to ensure complete elimination.

Brand names: MOOV LotionMOOV Head Lice Solution
Other names: MOOV Head Lice Solution

Beyond the preview

Go deeper on MOOV Lotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MOOV Lotion.

Explore the full profile